ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

(-)-Epicatechin Attenuates Myocardial Fibrosis and Apoptosis by Suppressing the Transforming Growth Factor-β1 Pathway in Acute Myocardial Infarction

Li, Jiawen; Zheng, Xingchang; Guo, Zuoming; Fan, Ying; Tian, Fang; Li, Teng; Pan, Qing; Liu, Fengyu; Liang, Xiao*哈尔滨医科大学; 1
JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS2023-10DOI: 10.23812/j.biol.regul.homeost.agents.20233710.500
21阅读
引用收藏
分享

摘要

Background: Cardiovascular disease (CAD) are the leading cause of human death, resulting in high morbidity, disability, and mortality. (-)-Epicatechin [(-)-EPI], a traditional Chinese medicine, has been used for treating CAD. This study aims to investigate the role of (-)-EPI in myocardial fibrosis (MF).Methods: We established an acute myocardial infarction (AMI) model mouse. The mice were fed with (-)-EPI and/or SRI-011381 hydrochloride (TGF-beta 1 agonist, HY-100347A) for 10 days. Hematoxylin and eosin (H&E) staining, Masson staining, and Western blot were used to confirm the effects of (-)-EPI alone or in combination with HY-100347A on the pathological injury, MF, and transforming growth factor-beta (TGF-beta) pathway in AMI model mice. In vitro experiments were conducted to verify whether (-)-EPI could affect the proliferation, apoptosis, and collagen deposition through the TGF-beta 1 pathway in myocardial fibroblasts under hypoxia. Results: In the AMI model mice, (-)-EPI was found to attenuate pathological injury and MF, and suppress the TGF-beta pathway. However, these inhibitory effects mediated by (-)-EPI could be reversed by the administration of the TGF-beta 1 pathway activator (HY-100347A). Moreover, myocardial fibroblasts were successfully extracted and certified. (-)-EPI inhibited apoptosis and collagen deposition in hypoxic myocardial fibroblasts by suppressing the TGF-beta 1 pathway (p < 0.05, p < 0.01, p < 0.001).Conclusions: Collectively, (-)-EPI has the potential to improve pathological injury and MF in AMI patients by suppressing the TGF-beta 1 pathway. This discovery provides new insights into the treatment of AMI.

学科与关键词

关键词
acute myocardial infarction (AMI)myocardial fibrosis (MF)(-)-epicatechin [(-)-EPI]transforming growth factor-beta 1 (TGF-beta 1)apoptosis
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS
发表日期
2023-10
卷期
第 37 卷, 第 10 期
页码
5165-5174
DOI
10.23812/j.biol.regul.homeost.agents.20233710.500
语言
ENGLISH
成果收录
SCIE
资助标注
Youth project of National Natural Science Foundation of China [82200482]; Fundamental Research Funds for the Provincial Universities [2021-KYYWF-0266]; Fourth Affiliated Hospital Of Harbin Medical University [HYDSYPY201905]

作者

  • L

    Li, Jiawen (第一作者)

    harbin med univ

  • Z

    Zheng, Xingchang

查看全部 9 位作者收起作者
  • G

    Guo, Zuoming

    harbin med univ

  • F

    Fan, Ying

    1 · harbin med univ

  • T

    Tian, Fang

    1 · harbin med univ

  • L

    Li, Teng

    1 · harbin med univ

  • P

    Pan, Qing

    1 · harbin med univ

  • L

    Liu, Fengyu

    1 · harbin med univ

  • L

    Liang, Xiao (通讯)

    1 · harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417